Mode
Text Size
Log in / Sign up
N/A N=212 Randomized Treatment

Tube Versus Trabeculectomy (TVT) Study

Glaucoma

Enrolled (actual)
212
Serious AEs
13.2%
Results posted
Nov 2015
Primary outcome: Primary: Change in Intraocular Pressure — 12.6; 14.4 mm Hg

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Baerveldt implant (Procedure); Trabeculectomy with mitomycin C (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Miami
Primary completion
Apr 2009

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Intraocular Pressure
12.6; 14.4
PRIMARY
Rate of Complications
39; 33; 38; 36
SECONDARY
Visual Acuity
56; 33; 44; 46
SECONDARY
Reoperations for Glaucoma
15; 20
SECONDARY
Need for Supplemental Medical Therapy
1.2; 1.4
SECONDARY
Failure Rate
46.9; 29.8

Summary

The purpose of the Tube Versus Trabeculectomy (TVT) Study is to compare the safety and efficacy of nonvalved tube shunt surgery to trabeculectomy with mitomycin C in patients with previous ocular surgery.

Eligibility Criteria

Inclusion Criteria

  • Age 18 to 85 years
  • Intraocular pressure greater than or equal to 18 mm Hg and less than or equal to 40 mm Hg
  • Previous trabeculectomy, cataract extraction with intraocular lens implantation, or both

Exclusion Criteria

  • Unwilling or unable to give consent, unwilling to accept randomization, or unable to return for scheduled protocol visits
  • Pregnant or nursing women
  • No light perception vision
  • Active iris neovascularization or active proliferative retinopathy
  • Iridocorneal endothelial syndrome
  • Epithelial or fibrous downgrowth
  • Aphakia
  • Vitreous in the anterior chamber for which a vitrectomy is anticipated
  • Chronic or recurrent uveitis
  • Severe posterior blepharitis
  • Unwilling to discontinue contact lens use after surgery
  • Previous cyclodestructive procedure, scleral buckling procedure, or presence of silicone oil
  • Conjunctival scarring precluding a trabeculectomy superiorly
  • Need for glaucoma surgery combined with other ocular procedures (eg cataract surgery, penetrating keratoplasty, or retinal surgery) or anticipated need for additional ocular surgery
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00306852). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search